| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1997;29:1178-1185.)
© 1997 American Heart Association, Inc.
Articles |
From the Renal Research Laboratory Fundación Jiménez Díaz, Universidad Autónoma, and the Department of Pathology (J.B.), Hospital Clínico, Universidad Complutense, Madrid, Spain.
Correspondence to Jesús Egido, MD, Servicio Nefrologia, Fundación Jiménez Díaz, Avda Reyes Católicos, 2, 28040 Madrid. E-mail egido{at}alpha2.ft.uam.es
Abstract Endothelin (ET-1) is a potent vasoconstrictor that plays an important role in the control of renal circulation and tubular function. The contribution of this peptide to the pathogenesis of systemic hypertension and renal failure remains largely undefined. In spontaneously hypertensive rats (SHR) uninephrectomized at 20 weeks of age (UNX-SHR) and followed until 45 weeks of age, we determined ET-1 gene expression in renal tissue by reverse transcriptionpolymerase chain reaction and its localization by in situ hybridization in paraffin-embedded kidney sections. Age-matched SHR and normotensive Wistar-Kyoto (WKY) rats were chosen as controls. At the end of the follow-up, UNX-SHR had high systolic blood pressure, intense proteinuria, mesangial expansion, focal and segmental glomerular sclerosis, and tubulointerstitial lesions. In relation to WKY and SHR, UNX-SHR exhibited an increase in ET-1 gene expression in renal cortex and medulla. By in situ hybridization and immunoperoxidase staining, an overexpression of ET-1 gene and protein were seen in mesangial and glomerular epithelial cells and in some proximal tubules and vessels. Angiotensin-converting enzyme (ACE) activity was significantly increased in the renal brush border. Since in mesangial cells, angiotensin II induces ET-1 synthesis, a group of UNX-SHR received the ACE inhibitor quinapril from the time of UNX. These animals had a decrease in blood pressure, proteinuria, and serum and brush border ACE activity and in the expression and synthesis of ET-1 in all renal areas. On the whole, these data show that UNX-SHR have an upregulation of ET-1 gene and protein in several structures of the kidney compared with SHR and WKY rats. Quinapril diminished ACE activity and ET-1 expression and synthesis coincidentally with an improvement in proteinuria and morphological lesions. The beneficial effects of ACE inhibitors may be due to the diminution of both angiotensin II and ET-1 generation.
Key Words: kidney rats, inbred SHR endothelin-1 ACE inhibition
This article has been cited by other articles:
![]() |
E. Gagliardini, D. Corna, C. Zoja, F. Sangalli, F. Carrara, M. Rossi, S. Conti, D. Rottoli, L. Longaretti, A. Remuzzi, et al. Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1448 - F1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Richter Role of endothelin in chronic renal failure--developments in renal involvement Rheumatology, October 1, 2006; 45(suppl_3): iii36 - iii38. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sorokin and D. E. Kohan Physiology and pathology of endothelin-1 in renal mesangium Am J Physiol Renal Physiol, October 1, 2003; 285(4): F579 - F589. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Moridaira, J. Morrissey, M. Fitzgerald, G. Guo, R. McCracken, T. Tolley, and S. Klahr ACE inhibition increases expression of the ETB receptor in kidneys of mice with unilateral obstruction Am J Physiol Renal Physiol, January 1, 2003; 284(1): F209 - F217. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fakhouri, S. Placier, R. Ardaillou, J.-C. Dussaule, and C. Chatziantoniou Angiotensin II Activates Collagen Type I Gene in the Renal Cortex and Aorta of Transgenic Mice through Interaction with Endothelin and TGF-{beta} J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2701 - 2710. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. LEHRKE, R. WALDHERR, E. RITZ, and J. WAGNER Renal Endothelin-1 and Endothelin Receptor Type B Expression in Glomerular Diseases with Proteinuria J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2321 - 2329. [Abstract] [Full Text] [PDF] |
||||
![]() |
Tong Chuang Feng, Wang Yui Ying, Ren Jang Hua, Y. Y Ji, and M. de Gasparo Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1): 19 - 24. [Abstract] [PDF] |
||||
![]() |
B. A. J. Frey, O. Grisk, N. Bandelow, S. Wussow, P. Bie, and R. Rettig Sodium homeostasis in transplanted rats with a spontaneously hypertensive rat kidney Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2000; 279(3): R1099 - R1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Boffa, P.-L. Tharaux, S. Placier, R. Ardaillou, J.-C. Dussaule, and C. Chatziantoniou Angiotensin II Activates Collagen Type I Gene in the Renal Vasculature of Transgenic Mice During Inhibition of Nitric Oxide Synthesis : Evidence for an Endothelin-Mediated Mechanism Circulation, November 2, 1999; 100(18): 1901 - 1908. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. MERVAALA, B. DEHMEL, V. GROSS, A. LIPPOLDT, J. BOHLENDER, A. F. MILIA, D. GANTEN, and F. C. LUFT Angiotensin-Converting Enzyme Inhibition and AT1 Receptor Blockade Modify the Pressure-Natriuresis Relationship by Additive Mechanisms in Rats with Human Renin and Angiotensinogen Genes J. Am. Soc. Nephrol., August 1, 1999; 10(8): 1669 - 1680. [Abstract] [Full Text] |
||||
![]() |
J. Maruyama, A. Yokochi, K. Maruyama, and S. Nosaka Acetylcholine-induced endothelium-derived contracting factor in hypoxic pulmonary hypertensive rats J Appl Physiol, May 1, 1999; 86(5): 1687 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Largo, D. Gomez-Garre, K. Soto, B. Marron, J. Blanco, R. M. Gazapo, J. J. Plaza, and J. Egido Angiotensin-Converting Enzyme Is Upregulated in the Proximal Tubules of Rats With Intense Proteinuria Hypertension, February 1, 1999; 33(2): 732 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Orth, J. P. Esslinger, K. Amann, U. Schwarz, M. Raschack, and E. Ritz Nephroprotection of an ETA-Receptor Blocker (LU 135252) in Salt-Loaded Uninephrectomized Stroke-Prone Spontaneously Hypertensive Rats Hypertension, April 1, 1998; 31(4): 995 - 1001. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |